AAON reported on August 13, 2025, that its forecast growth exceeded the industry average, driven by AI applications in diagnostics and drug discovery.
3 reports, 2 independent
Updated Jun 27
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
AAON reported on August 13, 2025, that its forecast growth exceeded the industry average, driven by AI applications in diagnostics and drug discovery.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.AAON leverages AI to drive growth in diagnostics and drug discovery.1 source
AAON receives a bullish thesis from Kairos Research, utilizes a specialized R&D center, and features leadership appointments including Matt Tobolski.1 source
Keep exploring
The entities involved
-
AAON
company
Nothing else this week.
Coverage
Newest first; wire copies grouped- Simply Wall St.AAON Second Quarter 2025 Earnings: Misses Expectations Explore AAON's Fair Values from the Community and select yours Revenue: US$311.6m (flat on 2Q 2024). Net income: US$15.5m (down 70% from 2Q 202
- Insider MonkeyAAON, Inc. (AAON): A Bull Case Theory We came across a bullish thesis on AAON, Inc. on Kairos Research’substack. In this article, we will summarize the bulls’ thesis on AAON. AAON, Inc. 's share was